How much does Huatangning (Dorzagliatin Tablets) Cost& price without insurance in China?
Huatangning® is the commercial brand name of Dorzagliatin Tablets, a first-in-class oral glucokinase activator independently developed by Hua Medicine of China. It targets the glucose kinase sensor in pancreas, intestine and liver to regulate blood glucose in a glucose-dependent manner, repairing the body’s blood glucose homeostasis function to achieve stable glycemic control.
Main Indications
Improvement of blood glucose control in adult patients with type 2 diabetes as monotherapy with diet and exercise intervention;
Combination use with metformin hydrochloride for patients with inadequate glycemic control on metformin monotherapy, to further optimize blood glucose management.
Common Side Effects
Rare severe risks: Hypoglycemia (mostly mild and manageable);
Common mild adverse reactions: Dizziness, elevated blood triglycerides, diarrhea, upper abdominal distension, flatulence and increased blood cholesterol levels.
Approval Status in China
Original drug Huatangning® (Dorzagliatin Tablets) was officially approved for marketing in China in September 2022, with the specification of 75mg per tablet. It is currently a prescription anti-diabetic drug included in China’s category B medical insurance.
Buy Huatangning (Dorzagliatin Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
